West Midlands Immunology Group - Minisymposium
Prospects for Immunotherapy - 31st May 1995
12.30-5.30pm University of Birmingham Medical School/Hospital
---------------------------------------------------------------
Speakers:
David Kerr (Birmingham) Immunomodulators in cancer:
Clinical perspectives
Herman Waldmann (Oxford) Prospects for increasing the
specificity of immunosuppression
Peter Searle (Birmingham) Prospects for immunotherapy of
cancer by gene therapy
Martin Glennie (Southampton) Activation and expansion of
cytotoxic T cells in vitro and
in vivo using bispecific and
trispecific antibodies
Adrian Robins (Nottingham) Anti-idiotypic immunisation in
colorectal cancer
Eric Culbert (Zeneca) Immunotherapy of autoimmune
disease by MHC class II blockade
----------------------------------------------------------------
All are welcome to attend this half day symposium organised by
the West Midlands Regional Immunology Group of the British
Society for Immunology. The meeting starts with a buffet lunch
provided with the help of our sponsors (BSI, R&D Systems,
Cambridge Bioscience, Promega, Pfizer, Becton Dickinson, Vector
Laboratories, Advanced Protein Products and Serotec).
There is no registration fee but advanced registration is needed
so we can guage the demand for lunch etc.
Enquiries and registration to Steve Young, Chair WMRIG:
s.p.young at bham.ac.uk
--
------
Dr Stephen Young | s.p.young at bham.ac.uk
Department of Rheumatology | tel: +44-(0)-121-414-6480
University of Birmingham | fax: +44-(0)-121-414-6794
Edgbaston |
Birmingham B15 2TT, UK |
